US Patent Issued to Takeda Pharmaceutical on June 23 for "Maribavir isomers, compositions, methods of making and methods of using" (Pennsylvania Inventor)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,368, issued on June 23, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Maribavir isomers, compositions, methods of making and methods of using" was invented by John D. Peabody III (West Chester, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to novel compositions and methods of using maribavir which enhance its effectiveness in medical therapy, as well as to maribavir isomers and methods of use thereof for counteracting the potentially adverse effects of maribavir isomerization in vivo in the event it occurs."

The patent was filed on Oct. 1, 2025, under Application No. 19/347,325.

*For further information...